Tasly Pharmaceutical Group Co Ltd

Common Name

Tasly Pharmaceutical Group

Country

China (Mainland)

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

10,958

Ticker

600535

Exchange

SHANGHAI STOCK EXCHANGE

Website

www.taslypharma.com

Description

Tasly Pharmaceutical Group Co., Ltd. is a prominent entity in the pharmaceutical industry, primarily involved in the research, development, production, and marketing of modern Traditional Chinese Medi... Show more

Income Statement Balance Sheet Group Entities

Tasly Pharmaceutical Group's Financial Statements Preview

Below are the financial statements of Tasly Pharmaceutical Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of CNY	2024 as of 2024-12-31	2023 as of 2023-12-31
Current assets	—	—
Monetary funds	2,993.56^a	4,450.6^a
Trading financial assets	524.72^a	300.71^a
Accounts receivable	780.14^a	688^a
Receivables financing	1,185.5^a	1,442.77^a
Prepayments	62.03^a	65.57^a
Other receivables	23.06^a	11.49^a
Inventories	1,711.92^a	1,747.69^a
Other current assets	29.69^a	25.85^a
Total current assets	7,310.62^a	8,732.68^a
Non-current assets	—	—
Long-term equity investments	1,309.34^a	1,415.41^a
Other non-current financial assets	511.87^a	638.22^a
Fixed assets	3,232.21^a	3,388.72^a
Construction in progress	221.76^a	153.87^a
Right-of-use assets	194.28^a	226.6^a
Intangible assets	604.17^a	573.64^a
Development expenditures	1,445.66^a	1,452.9^a
Long-term prepaid expenses	20.67^a	23.22^a
Deferred tax assets	53.17^a	50^a
Other non-current assets	72.54^a	43.14^a
Total non-current assets	7,665.68^a	7,981.6^a
Total assets	14,976.3^a	16,714.29^a
Current liabilities	—	—
Short-term borrowings	699.54^a	723.05^a
Notes payable	188.04^a	128.91^a
Accounts payable	418.77^a	443.82^a
Advances from customers	66.08^a	66.36^a
Contract liabilities	67.53^a	89.02^a
Employee benefits payable	113.61^a	114.3^a
Taxes payable	120.81^a	85.61^a
Other payables	38.26^a	183.91^a
Non-current liabilities due within one year	634.67^a	521.28^a
Other current liabilities	2.38^a	13.3^a
Total current liabilities	2,349.69^a	2,369.56^a
Non-current liabilities	—	—
Long-term borrowings	253.76^a	1,414.06^a
Lease liabilities	67.97^a	81.52^a
Deferred income	193.29^a	159.02^a
Deferred tax liabilities	0.4^a	0.11^a
Total non-current liabilities	515.41^a	1,654.72^a
Total liabilities	2,865.1^a	4,024.28^a
Owners' equity (or shareholders' equity)	—	—
Share capital	1,493.95^a	1,499.7^a
Capital reserves	458.96^a	958.08^a
Other comprehensive income	52.22^a	88^a
Surplus reserve	1,743.64^a	1,636.87^a
Retained earnings	8,154.56^a	8,291.75^a
Total equity attributable to owners of the parent	11,903.33^a	12,368.42^a
Non-controlling interests	207.86^a	321.59^a
Total shareholders' equity	12,111.19^a	12,690.01^a
Total liabilities and shareholders' equity	14,976.3^a	16,714.29^a
Goodwill	-	15.88^a
Less: Treasury shares	-	105.98^a

Download Data

Verified Sources Behind Tasly Pharmaceutical Group’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Tasly Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.

a. Tasly Pharmaceutical Group's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Tasly Pharmaceutical Group Co Ltd

Tasly Pharmaceutical Group's Financial Statements Preview

Verified Sources Behind Tasly Pharmaceutical Group’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Joincare Pharmaceutical Group Industry Co Ltd

Hansoh Pharmaceutical Group Company Ltd

WuXi Biologics (Cayman) Inc

Pharmaron Beijing Co Ltd

Genscript Biotech Corp

Zai Lab Ltd